Want to see KEQU full AI Analyst Report?
Total Valuation
Kewaunee Scientific has a market cap or net worth of $101.96M. The enterprise value is $129.95M.
Market Cap$101.96M
Enterprise Value$129.95M
Share Statistics
Kewaunee Scientific has 2,870,410 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,870,410
Owned by Insiders5.15%
Owned by Institutions13.69%
Financial Efficiency
Kewaunee Scientific’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 9.12%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)9.12%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee280.32K
Profits Per Employee0.00
Employee Count1,006
Asset Turnover1.58
Inventory Turnover6.60
Valuation Ratios
The current PE Ratio of Kewaunee Scientific is 10.6. Kewaunee Scientific’s PEG ratio is -0.71.
PE Ratio10.6
PS Ratio0.38
PB Ratio1.42
Price to Fair Value1.42
Price to FCF7.21
Price to Operating Cash Flow0.00
PEG Ratio-0.71
Income Statement
In the last 12 months, Kewaunee Scientific had revenue of 282.00M and earned 9.62M in profits. Earnings per share was 3.36.
Revenue282.00M
Gross Profit80.44M
Operating Income16.71M
Pretax Income13.73M
Net Income9.62M
EBITDA21.47M
Earnings Per Share (EPS)3.36
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Kewaunee Scientific pays an annual dividend of $0.19, resulting in a dividend yield of ―
Dividend Per Share$0.19
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.85
52-Week Price Change-40.21%
50-Day Moving Average37.65
200-Day Moving Average39.16
Relative Strength Index (RSI)42.74
Average Volume (3m)8.77K
Important Dates
Kewaunee Scientific upcoming earnings date is Sep 3, 2026, After Close (Confirmed).
Last Earnings DateJun 23, 2026
Next Earnings DateSep 3, 2026
Ex-Dividend Date―
Financial Position
Kewaunee Scientific as a current ratio of 2.18, with Debt / Equity ratio of 76.04%
Current Ratio2.18
Quick Ratio1.55
Debt to Market Cap0.47
Net Debt to EBITDA2.10
Interest Coverage Ratio4.33
Taxes
In the past 12 months, Kewaunee Scientific has paid 3.27M in taxes.
Income Tax3.27M
Effective Tax Rate0.24
Enterprise Valuation
Kewaunee Scientific EV to EBITDA ratio is 7.04, with an EV/FCF ratio of 10.29.
EV to Sales0.54
EV to EBITDA7.04
EV to Free Cash Flow10.29
EV to Operating Cash Flow8.11
Balance Sheet
Kewaunee Scientific has $11.62M in cash and marketable securities with $56.82M in debt, giving a net cash position of -$45.20M billion.
Cash & Marketable Securities$11.62M
Total Debt$56.82M
Net Cash-$45.20M
Net Cash Per Share-$15.75
Tangible Book Value Per Share$16.78
Margins
Gross margin is 28.52%, with operating margin of 5.93%, and net profit margin of 3.41%.
Gross Margin28.52%
Operating Margin5.93%
Pretax Margin4.87%
Net Profit Margin3.41%
EBITDA Margin7.61%
EBIT Margin5.93%
Analyst Forecast
The average price target for Kewaunee Scientific is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast17.27%
EPS Growth Forecast-15.71%